58 related articles for article (PubMed ID: 28286270)
1. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
2. USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
Yu J; Yuan S; Song J; Yu S
J Transl Med; 2023 Nov; 21(1):807. PubMed ID: 37957720
[TBL] [Abstract][Full Text] [Related]
3. miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17.
Liu J; Ye L; Lin K; Zhong T; Luo J; Wang T; Suo L; Mo Q; Li S; Chen Q; Yu Y
Mol Cell Biochem; 2023 Aug; 478(8):1727-1742. PubMed ID: 36565360
[TBL] [Abstract][Full Text] [Related]
4. Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway.
Song N; Cui K; Zeng L; Fan Y; Wang Z; Shi P; Su W; Wang H
J Proteomics; 2024 Jun; 301():105182. PubMed ID: 38697284
[TBL] [Abstract][Full Text] [Related]
5. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma.
Liu R; Zhang H; Wang X; Zhou L; Li H; Deng T; Qu Y; Duan J; Bai M; Ge S; Ning T; Zhang L; Huang D; Ba Y
Oncotarget; 2015 Dec; 6(41):43831-42. PubMed ID: 26517093
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP39 promotes SARS-CoV-2 replication by deubiquitinating and stabilizing the envelope protein.
Chen X; Tian L; Zhang L; Gao W; Yu M; Li Z; Zhang W
Antiviral Res; 2024 Jan; 221():105790. PubMed ID: 38158131
[TBL] [Abstract][Full Text] [Related]
7. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
Deng X; Ma J; Zhou W; Yuan Y; Wang B; Meng X
Lab Invest; 2023 Jun; 103(6):100122. PubMed ID: 36828188
[TBL] [Abstract][Full Text] [Related]
8. USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity.
Choi Y; Lee Y; Kim JS; Zhang P; Kim J
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892157
[TBL] [Abstract][Full Text] [Related]
9. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
Ma J; Zhou W; Yuan Y; Wang B; Meng X
Cancer Gene Ther; 2023 Aug; 30(8):1072-1083. PubMed ID: 37037907
[TBL] [Abstract][Full Text] [Related]
10. USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.
Zheng J; Wu S; Tang M; Xi S; Wang Y; Ren J; Luo H; Hu P; Sun L; Du Y; Yang H; Wang F; Gao H; Dai Z; Ou X; Li Y
Cell Death Dis; 2023 Oct; 14(10):670. PubMed ID: 37821439
[TBL] [Abstract][Full Text] [Related]
11. Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer.
Song Y; Song B; Yu Z; Li A; Xia L; Zhao Y; Lu Z; Li Z
Front Biosci (Landmark Ed); 2023 Nov; 28(11):316. PubMed ID: 38062811
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation.
Luo C; Yu Y; Zhu J; Chen L; Li D; Peng X; Liu Z; Li Q; Cao Q; Huang K; Yuan R
Cell Biosci; 2024 Mar; 14(1):35. PubMed ID: 38494478
[TBL] [Abstract][Full Text] [Related]
13. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z
Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526
[TBL] [Abstract][Full Text] [Related]
14. An NAD
Dong L; Yu L; Li H; Shi L; Luo Z; Zhao H; Liu Z; Yin G; Yan X; Lin Z
iScience; 2020 Aug; 23(8):101351. PubMed ID: 32711345
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro.
Gan Z; Han K; Lin S; Hu H; Shen Z; Min D
Biol Res; 2017 Apr; 50(1):15. PubMed ID: 28403900
[TBL] [Abstract][Full Text] [Related]
16. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
17. USP39 regulates the cell cycle, survival, and growth of human leukemia cells.
Liu C; Yao X; Li M; Xi Y; Zhao L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898977
[TBL] [Abstract][Full Text] [Related]
18. USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2.
Wu J; Chen Y; Geng G; Li L; Yin P; Nowsheen S; Li Y; Wu C; Liu J; Zhao F; Kim W; Zhou Q; Huang J; Guo G; Zhang C; Tu X; Gao X; Lou Z; Luo K; Qiao H; Yuan J
Cancer Lett; 2019 May; 449():114-124. PubMed ID: 30771428
[TBL] [Abstract][Full Text] [Related]
19. miR-133a, directly targeted USP39, suppresses cell proliferation and predicts prognosis of gastric cancer.
Dong X; Su H; Jiang F; Li H; Shi G; Fan L
Oncol Lett; 2018 Jun; 15(6):8311-8318. PubMed ID: 29805563
[TBL] [Abstract][Full Text] [Related]
20. USP39 regulates the growth of SMMC-7721 cells via FoxM1.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Ding Y
Exp Ther Med; 2017 Apr; 13(4):1506-1513. PubMed ID: 28413501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
